Qdenga powder and solvent for solution for injection
- Licence status
- Active substances
- Dengue virus, serotype 2, expressing Dengue virus, serotype 1, surface proteins, live, attenuated, Dengue virus, serotype 2, live, attenuated, Dengue virus, serotype 2, expressing Dengue virus, serotype 3, surface proteins, live, attenuated, Dengue virus, serotype 2, expressing Dengue virus, serotype 4, surface proteins, live, attenuated
- Dosage Form
- Powder and solvent for solution for injection
- Licence number
- EU/1/22/1699/001
- Licence holder
- Takeda GmbH
Product documents
Licence information
- ATC code
- J07B VIRAL VACCINES, J07BX04 Dengue virus vaccine
- Legal supply status
- Product subject to prescription which may not be renewed (A)
- Place of sale
- Supply through pharmacies only
- Marketing availability
- Unknown
- Advertising conditions
- Advertising to healthcare professionals only
- Licence issued
- 05/12/2022